SCHEMBL6557485

SCHEMBL6557485

CC(NC(C)C1CCCCC1)C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
MMP2 P08253 2/20 0.47
CA9 Q16790 2/20 0.47
SHBG P04278 1/20 0.42
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EPHX1 P07099 3/20 0.38
DAPK3 O43293 1/20 0.35
ROCK2 O75116 1/20 0.35
CHEK2 O96017 1/20 0.35
PIM1 P11309 1/20 0.35
PLK1 P53350 1/20 0.35
ROCK1 Q13464 1/20 0.35
CDC42BPA Q5VT25 1/20 0.35
AURKB Q96GD4 1/20 0.35
PLK3 Q9H4B4 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25589732 0.92 CA12 (0.45) CA12CA1CA2MMP2CA9
SCHEMBL14011250 0.92 CA12 (0.45) CA12CA1CA2MMP2CA9
SCHEMBL14011252 0.88 CA12 (0.42) CA12CA1CA2MMP2CA9
SCHEMBL6177824 0.84 EPHX2 (0.33) CA12CA1CA2MMP2CA9
SCHEMBL10093853 0.82 TDP1 (0.39) CA12CA1CA2MMP2CA9
SCHEMBL18995300 0.82 TDP1 (0.39) CA12CA1CA2MMP2CA9
SCHEMBL172674 0.81 SHBG (0.48) CA12CA1CA2MMP2CA9
SCHEMBL23020214 0.80 CA12 (0.45) CA12CA1CA2MMP2CA9
SCHEMBL22924061 0.80 CA12 (0.45) CA12CA1CA2MMP2CA9
SCHEMBL22924338 0.80 CA12 (0.45) CA12CA1CA2MMP2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109336887-B Benzimidazole chiral heterocyclic compound and preparation method and application thereof 中山大学 2021-12-17 CN claimed
EP-0467727-B1 Esterification process of hydroxybenzoic acids RHONE POULENC CHIMIE (FR) 1995-09-13 EP claimed
EP-4357382-B1 IONICALLY MODIFIED POLYISOCYANATE MIXTURE COVESTRO DEUTSCHLAND AG (DE) 2025-07-23 EP disclosed
EP-4357382-A1 IONICALLY MODIFIED POLYISOCYANATE MIXTURE Covestro Deutschland AG (DE) 2024-04-24 EP disclosed
EP-4107198-B1 POLYISOCYANATE PREPARATIONS COVESTRO DEUTSCHLAND AG (DE) 2024-03-13 EP disclosed
EP-3560975-B2 IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-12-06 EP disclosed
EP-3724251-B2 IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-11-22 EP disclosed
EP-3851472-B1 IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-06-07 EP disclosed
EP-4107198-A1 POLYISOCYANATE PREPARATIONS Covestro Deutschland AG (DE) 2022-12-28 EP disclosed
CN-109336887-B Benzimidazole chiral heterocyclic compound and preparation method and application thereof 中山大学 2021-12-17 CN disclosed
EP-3875513-A1 IONICALLY HYDROPHILIZED POLYISOCYANATES AND RADICAL SCAVENGER AND/OR PEROXIDE DECOMPOSITION AGENT Covestro Intellectual Property GmbH & Co. KG (DE) 2021-09-08 EP disclosed
EP-0905131-B1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them AVENTIS PHARMA GMBH (DE) 2002-04-10 EP disclosed
EP-0915087-A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-05-12 EP disclosed
EP-0913396-A2 Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-05-06 EP disclosed
EP-0908464-A1 Process for the preparation of hydroxyphosphonates and their use as flame retardants in polymers BASF AKTIENGESELLSCHAFT (DE) 1999-04-14 EP disclosed
EP-0906911-A1 Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-04-07 EP disclosed
EP-0905131-A1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-03-31 EP disclosed
EP-0861836-A1 Sulfonamido substituted condensed, seven-membered ring compounds with potassium channel blocking activity HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-02 EP disclosed
EP-0847996-A1 Sulfonamide substituted compounds as K-channel blockers HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-17 EP disclosed
WO-1995016726-A1 METHOD OF PRODUCING MALEINIMIDE POLYMERS AND USE OF SUCH POLYMERS BASF AKTIENGESELLSCHAFT (DE) 1995-06-22 WO disclosed